SEC Comment Letter 0000000000-23-009230 to Huaizhong Health Group, Inc. (ADAD) (CIK 0001593204)
Huaizhong Health Group, Inc. (ADAD) (CIK 0001593204)
Date: Aug. 22, 2023 · CIK: 0001593204 · Accession: 0000000000-23-009230
AI Filing Summary & Sentiment
File numbers found in text: 000-55369
Letter
United States securities and exchange commission logo August 22, 2023 Yuantong Wang Chief Executive Officer Huaizhong Health Group, Inc. Tianan Technology Park 13/F Headquarters Center Building 16 555 Panyu North Ave, Panyu District Guangzhou City, China Re:Huaizhong Health Group, Inc. Form 10-K for the Fiscal Year ended October 31, 2022 Filed March 27, 2023 File No. 000-55369 Dear Yuantong Wang: We issued comments to you on the above captioned filing on April 12, 2023 and June 2, 2023. As of the date of this letter, these comments remain outstanding and unresolved notwithstanding your letters of May 24, 2023 and August 1, 2023. We expect you to provide a complete, substantive response to these comments by September 6, 2023. If you do not respond, we will, consistent with our obligations under the federal securities laws, decide how we will seek to resolve material outstanding comments and complete our review of your filing and your disclosure. Among other things, we may decide to release publicly, through the agency's EDGAR system, all correspondence, including this letter, relating to the review of your filings, consistent with the staff's decision to publicly release comment and response letters relating to disclosure filings it has reviewed. Please contact Robert Babula, Staff Accountant, at (202) 551-3339 or Gus Rodriguez, Staff Accountant, at (202) 551-3752 with any questions. Sincerely, Division of Corporation Finance Office of Energy & Transportation
Show Raw Text
United States securities and exchange commission logo
August 22, 2023
Yuantong Wang
Chief Executive Officer
Huaizhong Health Group, Inc.
Tianan Technology Park
13/F Headquarters Center Building 16
555 Panyu North Ave, Panyu District
Guangzhou City, China
Re:Huaizhong Health Group, Inc.
Form 10-K for the Fiscal Year ended October 31, 2022
Filed March 27, 2023
File No. 000-55369
Dear Yuantong Wang:
We issued comments to you on the above captioned filing on April 12, 2023 and June 2,
2023. As of the date of this letter, these comments remain outstanding and unresolved
notwithstanding your letters of May 24, 2023 and August 1, 2023. We expect you to provide a
complete, substantive response to these comments by September 6, 2023.
If you do not respond, we will, consistent with our obligations under the federal securities
laws, decide how we will seek to resolve material outstanding comments and complete our
review of your filing and your disclosure. Among other things, we may decide to release
publicly, through the agency's EDGAR system, all correspondence, including this letter, relating
to the review of your filings, consistent with the staff's decision to publicly release comment and
response letters relating to disclosure filings it has reviewed.
Please contact Robert Babula, Staff Accountant, at (202) 551-3339 or Gus Rodriguez,
Staff Accountant, at (202) 551-3752 with any questions.
Sincerely,
Division of Corporation Finance
Office of Energy & Transportation